Abstract Astrocytes respond to a variety of CNS injuries by cellular enlargement, process outgrowth, and upregulation of extracellular matrix proteins that function to prevent expansion of the injured region. This astrocytic response, though critical to the acute injury response, results in the formation of a glial scar that inhibits neural repair. Scar-forming cells (fibroblasts) in the heart can undergo mesenchymalendothelial transition into endothelial cell fates following cardiac injury in a process dependent on p53 that can be modulated to augment cardiac repair. Here, we sought to determine whether astrocytes, as the primary scar-forming cell of the CNS, are able to undergo a similar cellular phenotypic transition and adopt endothelial cell fates. Serum deprivation of differentiated astrocytes resulted in a change in cellular morphology and upregulation of endothelial cell marker genes. In a tube formation assay, serum-deprived astrocytes showed a substantial increase in vessel-like morphology that was comparable to human umbilical vein endothelial cells and dependent on p53. RNA sequencing of serum-deprived astrocytes demonstrated an expression profile that mimicked an endothelial rather than astrocyte transcriptome and identified p53 and angiogenic pathways as specifically upregulated. Inhibition of p53 with genetic or pharmacologic strategies inhibited astrocyte-endothelial transition. Astrocyte-endothelial cell transition could also be modulated by miR-194, a microRNA downstream of p53 that affects expression of genes regulating angiogenesis. Together, these studies demonstrate that differentiated astrocytes retain a stimulus-dependent mechanism for cellular transition into an endothelial phenotype that may modulate formation of the glial scar and promote injury-induced angiogenesis.
Introduction
Critical barriers to the recovery of function after central nervous system injury are the formation of a glial scar Electronic supplementary material The online version of this article (doi:10.1007/s12035-016-9974-3) contains supplementary material, which is available to authorized users. and insufficient vascular supply to recovering tissue. While a regenerative response replenishes lost parenchyma with new viable tissue and can lead to structural and functional recovery, a scarring response replaces damaged tissue with scar tissue and results in significant impairment of tissue structure and function. In the CNS, astrocytes play a central role in scar formation [1] . In the setting of injury, resident astrocytes become reactive, changing their cellular morphology by undergoing process extension, increasing the expression of glial fibrillary acidic protein (GFAP) [2] , and can proliferate [3] . They also notably increase the expression of various extracellular matrix proteins including chondroitin proteoglycans, laminin, tenascin C, and fibronectin that form a glial scar around the injury core. While such scarring is beneficial in limiting the expansion of injury, it ultimately limits axonal outgrowth and impairs recovery of function [4, 5] . Ischemic injury in the brain also stimulates angiogenesis in adjacent peri-infarct tissue bringing additional blood flow and reparative neural precursor cells to the peri-infarct region [6, 7] . Reactive gliosis and post-ischemic neovascularization occur early on after injury, and a strong spatio-temporal interplay of these processes is thought to affect the final burden of glial scarring and functional recovery [8] . Not surprisingly then, decreasing astrocyte proliferation, reactive gliosis, and growth inhibitory signaling all improve recovery [9] [10] [11] .
Recent data has suggested that scar formation in post-mitotic tissues might be amenable to modulation by manipulating the plasticity of scar-forming cells. Ubil et al. [12] showed that a population of resident cardiac fibroblasts that contribute to post-ischemic cardiac scar formation undergo a cellular phenotype change into functional endothelial cells. This process is mediated by cell stress and dependent on p53. Moreover, p53 agonists can be used to promote fibroblast-endothelial cell transitions to increase neovascularization, decrease scarring, and enhance cardiac function after ischemic injury. Using a paradigm of differentiated astroglial cells in culture, we examined whether astroglial cells could change their fate to an endothelial phenotype.
Here, we show that under conditions of cellular stress triggered by serum deprivation, differentiated astrocytes are capable of undergoing a phenotypic cellular transition into endothelial cells. Astrocytes exposed to serum deprivation upregulate endothelial gene markers including a number of brain-specific endothelial cell markers, behave like endothelial cells in an angiogenic assay, and adopt an endothelial celllike transcriptome. In addition, we show that this cellular transition is dependent on p53 and that the p53-responsive miR-194 can drive this cellular phenotype change. Strategies to promote astrocyte-to-endothelial transition after CNS injury may hold therapeutic promise by modulating glial scar formation and promoting neovascularization.
Materials and Methods

Animal Care and Use
All animal studies were approved by the Institutional Animal Care and Use Committee at the University of California, LA. Wild-type C57/Bl6 mice were purchased from Jackson Laboratories. p53-Heterozygote knockout mice were purchased from Jackson Labs and bred to homozygous null.
NPC Isolation
Neural progenitor cells (NPCs) were isolated from the subventricular zone (SVZ) of post-natal day 7 (P7) C57BL/6 or p53-heterozygote or p53-null mice. SVZ tissue was microdissected with a curette from 2-mm-thick coronal sections in Hibernate medium (Brain Bits). Four SVZ regions from each P3 mouse were pooled and dissociated in digestion medium (2 mg/ml papain (Worthington) and 200 U/ml DNase I (Roche) in Hibernate medium without calcium), triturated, filtered through 40 μm cell strainers, and resuspended in NPC medium (Dulbecco's modified Eagle's medium/F12 containing 1X B27 supplement (Life Technologies), 20 ng/ml of epidermal growth factor (EGF), 10 ng/ml of basic fibroblast growth factor (bFGF), heparin (5 μg/mL), 100 U penicillin, and 0.1 mg/ml streptomycin (Life Technologies)). NPCs were grown as neurosphere suspension cultures as previously described (1) and passaged every 7 days, with addition of 20 ng/ml EGF and 10 ng/ml bFGF every 2 days.
NPC to Astrocyte Differentiation and Serum Deprivation
At passage 2, neurospheres were dissociated to single cells with Accumax enzyme and plated at 1.4 × 10 4 cells/cm 2 in T75 flasks coated with 80 μg/ml growth-factor-reduced matrigel (Corning). At 3 days after plating, NPCs were rinsed with phosphate buffered saline (PBS) and switched to astrocyte differentiation medium (neurobasal medium (Life Technologies) containing 1X B27 supplement, 1X Glutamatax, and 5 % fetal bovine serum (FBS)) [13] . Cultures achieved high astrocytic purity after 3 days in differentiation medium by visual morphology and astrocytic phenotyping via immunocytochemistry and quantitative PCR (qPCR) for astrocytic markers (Supplemental Figure 1) . All experimental manipulations (tube formation assays, serum deprivation, and p53 gain-and loss-of-function) were started 3 days after induction of astrocytic differentiation. To serum deprive cells, astrocyte differentiation media was removed and cells washed two times in sterile PBS. Astrocyte differentiation media either containing 5 % or 0 % FBS was added and cells cultured for varying time points (24, 48 , or 72 h).
RNA Isolation and qPCR
Following serum deprivation, cells were harvested by trypsinization and centrifugation or direct lysis. RNA isolation was performed using Nucleospin miRNA collection kit (Clontech) to collect large and small RNA. Fifty 500 ng of total RNA was used to generate first-strand cDNA (Superscript VILO, Thermo Fisher). Real-time qPCR was performed using a Roche Lightcycler 480 and SYBR green Master Mix (Roche). Primers for VECAD, eNOS, PECAM, Claudin 5, and six brain-specific endothelial genes identified based on comparative transcriptional analysis of the mouse blood-brain barrier were used [14] . Primer sequences are available in Supplemental Table 1 . Fold expression values and 95 % confidence intervals were calculated using established methodology. One-way ANOVA with post hoc Student's t test and Bonferroni correction for multiple comparisons using delta-Ct values were used to determine statistical significance (p < 0.005). Representative data from a single experiment are presented through cultures, and qPCR analysis were performed in triplicate with similar results. For qPCR in p53-null mice and in miR-194 gain and loss of function studies, we utilized a custom qPCR array employing selected genes from above biologic replicates and technical triplicates. Raw Ct values were analyzed using SABiosciences array analysis software.
Immunocytochemistry
To determine culture purity and measure the upregulation of endothelial markers at the protein level, NPC were differentiated into astrocytes on matrigel-coated glass coverslips. Following serum deprivation, cells were immediately fixed with 4 % paraformaldehyde and stored at 4°C until immunocytochemistry. Cells were washed twice with PBS pH 7.4, blocked and permeabilized with 5 % normal donkey serum (Jackson Immunoresearch) and 0.3 % TX-100 (Sigma) in 1X PBS for 45 min at RT. The following primary antibodies were used: rat anti-GFAP (Life Technologies), rabbit anti-ALDH1L1 (Abcam), rabbit anti-VECAD (Abcam), rabbit anti-CD31 (Bioss), rabbit anti-claudin (Abcam), and rabbit anti-eNOS (Abcam). Primary antibody incubations occurred at 4°C for 24 h, after which cells were washed twice with PBS and appropriate donkey anti-rat or donkey anti-rabbit secondary antibodies (Jackson Immunoresearch) along with DAPI (Life Technology) were added for 45 min at RT. Cells were again washed twice with PBS and coverslips inverted onto glass slides. Cellular imaging was performed using a Nikon C2 confocal microscope. Quantitation was performed by measuring the total and VECAD-positive cells in each of five 60X fields per time point. One-way ANOVA with post hoc Student's t test and Bonferroni correction for multiple comparisons were used to determine statistical significance.
Tube Formation Assay
This assay was performed generally as previously reported [15] . For each assay, 1.5 × 10 4 cells/well were plated on undiluted growth-factor-reduced matrigel and cultured in triplicate for 24 h in astrocyte differentiation medium with (5 %) or without (0 %) serum. Pifithrin-α 100 μM (P4359, Sigma) or RITA 0.1 μM (506149, EMD Chemicals) were added to the cells cultured with the above culture medium. NPCs and human umbilical vein endothelial cells (HUVECs) were used as controls. After 24 h of growth, cells were fixed and stained using Acti-Stain (Cytoskeleton, Inc.). Confocal z-stack images of each well were obtained at ×4 magnification and maximum intensity projection images were analyzed using AngioTool [16] with statistical significance determined using a one-way ANOVA with post hoc Student's t test and Bonferroni correction for multiple comparisons.
RNA-seq and Bioinformatic Analysis
Duplicate cultures of astrocytes were cultured from NPCs as above and serum deprived for 48 h. RNA was isolated by direct lysis and purified as above. RINs ranged from 7.8 to 8.6. Serum-deprived primary cardiac fibroblast cultures and RNA were isolated as previously reported [12] . RNA-sequencing of astrocytes was carried out by the UCLA Neuroscience Genomics Core using TrueSeq with RiboZero treatment. Samples were sequenced using paired end reads resulting in 50 M reads per sample. RNA sequencing of cardiac fibroblasts was performed using standard Illumina RNA-seq library construction protocols and sequenced on the Illumina HiSeq 2000. Reads were aligned to the latest mouse_mm10 reference genome using the STAR (ver 2.4.0) spliced read aligner [17] . Read counts for RefSeq genes were generated by HT-seq [18] . Differentially expressed genes (DEG) were analyzed using both the negative binomial R/Bioconductor EdgeR package and Limma-voom analysis packages to reduce the likelihood of a type I error. DEG were selected using an FDR of <0.01 (EdgeR package). Enrichr pathway analysis was performed using both up and downregulated gene lists [19] . For cell type enrichment analysis, expression values for different cells types were downloaded [20] . For each cell type, enrichment index was calculated log2([FPKM_one_cell_type]/ [FPKM_avg_all_other_cell_types]). Top 500 cell-specific genes were selected and plotted against log2 fold change from serum-deprived astrocytes compared to control.
miR-194 qPCR and Gain and Loss of Function
Astrocyte cultures were generated as above and cultured in 5 or 0 % FBS for 48 h. RNA was isolated as above and small RNA fractions were generated. miR cDNA was generated using the NCode VILO cDNA synthesis protocol (Thermo Fisher).
Primers for miR-194, miR-103a, and snoRNA-202 were generated using miR primer software [21] (sequences available in Supplemental Table 1 ). To determine the effect of miR-194 gain and loss of function, astrocyte cultures were generated as above. After 3 days of astrocyte differentiation, cultures were transfected with miR-194 mimic or inhibitor siRNAs (Ambion/ ThermoFisher) using RNAiMAX and standardized manufacturer protocol. Immediately following the initiation of transfection, cultures were changed to either 5 or 0 % FBS media and cultured for an additional 48 h. Transfection efficiency was measured by red fluorescent oligodT co-transfection. RNA was isolated as above. Duplicate cultures were plated on glass coverslips and fixed and stained as above.
Results
Serum Deprivation in Cultured Astrocytes Increases Endothelial Gene Expression
To determine if astrocytes were capable of cellular transition towards an endothelial phenotype, we established a culture paradigm with induced differentiation of subventricular zone-derived neural precursor cells (NPCs) from post-natal day 7 mice [22] into type II astrocytes (Fig. 1a) . This resulted in a highly pure culture of primary astrocytes showing ubiquitous GFAP staining by immunofluorescence (Supplemental Figure 1a) and by qPCR, a 15-fold increase in ALDH1L1 and 6-fold increase in GFAP with no measureable expression of neuronal or oligodendrocytic markers (Supplemental Figure 1b) . As serum-deprivation-induced stress has been shown to induce endothelial transition of cardiac fibroblasts, scar-forming cells that modulate extracellular matrix and provide tissue barrier protection after injury (similar to astrocytes), we subjected NPC-derived type II astrocytes to serum deprivation to determine if they were capable of adoption of an endothelial phenotype. Serum deprivation resulted in significant increased expression of endothelial specific genes including VECAD and eNOS as well as several brain-specific endothelial genes [14] (Fig. 1b) . After serum deprivation, the number of VECAD-positive cells increase from zero in control and after 24 h of serum deprivation to 23.5 % (±0.34; p = 0.002) at 48 h and 35.3 % (±1.03; p = 0.000002) at 72 h (Fig. 2) . Serum deprivation also produced an increase in GLUT-1 expression (Supplemental Figure 2) . Notably, we also cultured astrocytes and NPCs under conditions of serum deprivation with 1 % O 2 , but hypoxia did not have any additive effect on the expression of endothelial markers (Supplemental Figure 3) . These indicate that serum deprivation in vitro induces the beginning of an endothelial phenotype in astrocytes by increasing the expression endothelial specific genes in astrocytes.
Astrocytes Form Tubes in an Angiogenic Tube Formation Assay
To determine whether serum-deprived astrocytes would exhibit functional characteristics of endothelial cells, we performed a tube formation assay [15] . This is a wellcharacterized in vitro assay that has been extensively used to study angiogenesis, involves cell migration within a threedimensional extracellular matrix gel, and measures a unique angiogenic function of endothelial cells [15] . NPC-derived astrocytes were seeded onto matrigel-coated tissue culture dishes and subjected to control or serum-deprived conditions. Twenty-four hours after seeding, astrocytes grown in serum containing media showed no evidence of tube formation and tended to cluster into small spheroids (Fig. 3a, c) . In contrast, astrocytes subjected to serum deprivation exhibited robust tube formation (Fig. 3b, d ). Tube formation was associated with an increase in VECAD immunoreactivity (Fig. 3e, f ) that often coincided with decreased GFAP immunoreactivity within the tube formation assay. Taken together, these observations strongly suggest that astrocytes following transition to an endothelial cell phenotype exhibit functional characteristics of endothelial cells. p53-Mediated stress pathways have been shown to regulate fibroblast endothelial cellular transitions in the myocardium [12] . Serum-deprived astrocytes show dramatic increases in both the number of junctions ( Fig. 3g ; p = 0.27 × 10 −6 ) and the average vessel length ( Fig. 3h ; p = 0.18 × 10
−6
). Inhibition of p53 signaling using the small molecule p53 antagonist, pifithrin-α (100 μM) [23] dramatically decreased tube formation (p = 0.14 × 10 −6 (junctions); p = 0.24 × 10 −6 (average vessel length)). In contrast, addition of the small molecule p53 agonist, RITA (100 nM) [24] did not further augment tube formation. Serum-deprived astrocytes behaved similarly to HUVECs with respect to average vessel length (Fig. 3c ) but formed tubes with a higher overall complexity than HUVECs, reflected in a greater number of junctions seen with serum deprivation in astrocytes compared to HUVECs (p = 1.0 × 10
).
Transcriptional Analysis of Astrocyte-Endothelial Cell Transition
To better understand the molecular pathways triggered by serum deprivation in cultured astroglial cells, we performed RNA-seq and comparative bioinformatics on serum-deprived astrocytes. Figure 4 illustrates the top 100 DEG with the highest read counts (FDR < 0.01). In total, 376 genes were upregulated in serum-deprived astrocytes while 614 genes were downregulated (FDR < 0.01) (Supplemental Table 2 ). We first performed gene ontology and pathway analysis on significantly upregulated genes using the Enrichr [19] database. Gene ontology of biological processes demonstrates genes/pathways regulating cell-cell adhesion via the plasma membrane, cell-cell adhesion, and the regulation of response to wounding (Supplemental Figure 4) . Pathway analysis directly implicates the p53 signaling pathway ( Fig. 5a ; Biocarta 2015; p = 0.0039) as well as VEGF and angiogenesis pathways ( Figure 5 ). To determine how closely the transcriptional profile of serum-deprived astrocytes correlates with existing cell-type-specific databases, we compared the DEG in our serum-deprived astrocyte cultures with existing brain cell-specific RNA-seq data sets [25] by plotting the top 500 cell-type-specific genes characterizing astrocytes (upper panel) and endothelia (lower panel) from the Zhang et al. database against log2 fold change of each of those genes in our data set (Fig. 5c ). Only six of the highly expressed astrocyte genes showed >2 log2 fold change in serum-deprived astrocytes (far right, upper panel) with a flat trendline (red line; upper panel) when comparing all genes. In contrast, 19 of the brain endothelial specific genes showed >2 log2 fold change in serumdeprived astrocytes, resulting in a shift of the trendline (red line; lower panel) towards an endothelial phenotype. Finally, we compared the DEGs found in our serumdeprived astrocytes with DEGs from serum-deprived primary cardiac fibroblasts that are known to be under similar cellular phenotype plasticity towards an endothelial phenotype [12] . Despite the large difference in cellular background between cardiac fibroblasts and astrocytes, we found 171 commonly upregulated genes (pHyper = 0.12117) including as well as 230 commonly downregulated genes (pHyper = 0.0832) (Fig. 5d) . Common upregulated genes represented 4.86 % of the total upregulated genes in fibroblasts and 31.0 % in astrocytes. Common downregulated genes represented 7.13 % of the total downregulated genes in fibroblasts and 28.5 % in astrocytes. A total of 49 differentially expressed transcription factors were common between the two serum-deprived cell types (Supplemental Figure 6a and b; Supplemental Table 3 ). Enrichr pathway analysis of both the up-(logFC > 0 for both cell populations) and Fig. 1 Cultured astrocytes were generated from subventricular neural precursors grown as neurospheres by culturing on growth-factor-reduced matrigel for 3 days followed by media change to defined media with 5 % fetal bovine serum (FBS) for 3 days. This generated a highly pure culture of Type II astrocytes (a). After differentiation as in (a), 24 and 48 h of serum deprivation resulted in significant increases in a number of endothelial genes by qPCR, including a number of brain-specific endothelial genes [14] (b). Asterisk indicates p < 0.005, n = 3 downregulated (logFC < 0) shared transcription factors (FDR < 0.1) implicates the p300/CBP signaling system (Supplemental Figure 6c and d) . Together, these data indicate that astrocytes do harbor intrinsic cellular plasticity towards an endothelial phenotype with a gene expression profile that shares features with both known endothelial transcriptional databases and other cell types that have a similar cellular plasticity potential.
p53 Is Required for Astrocyte-Endothelial Cell Transition
To confirm the role of p53 on astroglial cellular plasticity towards an endothelial phenotype, we generated NPC cultures from P7 p53-null and p53-heterozygote knockout mice [26] . We did not observe any significant differences in growth rate, cellular size or morphology, or astrocyte differentiation from NPCs in WT, p53-heterozygote, or p53-null cultures (data not shown). When seeded into a tube formation assay, both partial and complete lack of p53 significantly inhibited the formation of tubes (Fig. 6a-c) . Wild-type astrocytes from p53-null littermates formed robust tubes in conditions of serum deprivation as we had observed in prior studies (Fig. 6a) . p53-Heterozygote astrocytes appeared to form neighboring links and to partially change cellular morphology to a more linear morphology but did not generate substantial tubes (Fig. 6b) . p53-Null astrocytes did not show the same degree of cellular morphology change nor exhibited any substantial tube formation (Fig. 6c) . The number of junctions ( Fig. 6d ) and average vessel length (Fig. 6e) were significantly reduced in both the p53-heterozygote and p53-null astrocyte cultures upon serum deprivation to levels that resemble astrocytes cultured in serum conditions. These observations suggest that p53 is required for this form of astrocyte-endothelial cellular transition. To confirm the effect of p53 deletion on endothelial gene expression, we developed a focused endothelial gene qPCR array comprising both canonical endothelial and brain-specific endothelial markers (VECAD, eNOS, claudin-5, slc22a8, slc1a4, and slc1c1) that were observed to be consistently upregulated in serum-deprived astrocytes. Compared to gene expression in wild-type serum-deprived astrocytes, p53-null serum-deprived astrocytes demonstrated a significant downregulation of these endothelial genes (Fig. 6f) . Inset cluster dendrogram (upper right, Fig. 6f) indicates that a variable gene expression profile was observed in p53-heterozygote serum-deprived astrocytes (middle column), while global gene expression decreased for 6/7 genes in the array in p53-null astrocytes. Taken together, these data confirm the necessity of p53 on astroglial cellular plasticity towards an endothelial phenotype. Next we investigated downstream mechanisms from p53, particularly the role of miR-194. miR-194 is a p53-dependent microRNA [27] that regulates expression of thrombospondin (TSP-1) [28] , an anti-angiogenic factor that is partially secreted by astrocytes [29] . miR-194 is increased 4.4-fold with serum deprivation in astrocytes during astroglial-endothelial cellular transition (p = 0.05; CI 3.47-5.59) (Fig. 7a) . TSP-1 expression was robust in control cultures (Fig. 7b ) but decreased in serum-deprived astrocytes (Fig. 7c) . To determine if miR- Serum deprivation resulted in a significant increase in both measurements (*p < 0.01). Addition of 100 nM RITA together with serum deprivation did not result in further increases in tube formation, while serum deprivation in the presence of pifithrin-α (100 μM) completely blocked tube formation (**p < 0.01). The average vessel length of serum-deprived astrocytes was similar to that of human umbilical vein endothelial cells (HUVECs), although the number of junctions was substantially higher in serum-deprived astrocytes ((g); p < 0.01)
194 could augment astroglial-endothelial cellular transition, we transfected differentiated astrocyte cultures with synthetic miR-194 mimic, miR-194 inhibitor, or vehicle only (along with a red fluorescent indicator to determine transfection efficiency) at the time of serum deprivation. Vehicle-only transfections demonstrated the typical morphology of serumdeprived astrocytes after 48 h with a high transfection efficiency (Fig. 7d) . miR-194 mimic cultures showed a greater degree of cellular elongation after 48 h of serum deprivation (Fig. 7e) . Gene expression analysis using a focused endothelial qPCR array demonstrated that miR-194 further drives expression of endothelial specific genes compared to vehicle-only transfected serum-deprived astrocytes (red circles, Fig. 7f ). Cluster dendrogram (inset, Fig. 7f ) illustrates the specific expression level of individual genes by culture and transfection condition. miR-194 inhibition reduces the expression of 4/8 of the endothelial specific genes compared to vehicle only transfected serum-deprived astrocytes (green circles, Supplemental Figure 7) . Thus, miR-194, a p53-responsive microRNA, appears at least in part to mediate astroglialendothelial cellular transition.
Discussion
The ability of differentiated cells to change their cellular phenotype (transdiffferentiation) is known to occur during wound healing [30] . Here, we demonstrate that differentiated astroc y t e s i n v it r o r e t a in t h e i n t r i n s i c p o t e n t i a l fo r Fig. 4 Cluster dendrogram of the top 100 differentially expressed genes (DEG) using false discovery rate of <0.01 by EdgeR analysis from RNA-seq comparing serum-deprived astrocytes (AstrocyteSF) vs. astrocytes cultured in 5 % FBS (AstrocyteControl). Red cells are increased expression; blue cells are decreased expression transdifferentiation towards an endothelial phenotype under the cellular stress of serum deprivation. This stimulus provokes a pro-angiogenic pathway that requires p53 but is not augmented by enhancing p53 activity and can be at least partially driven by the p53-responsive miR-194. These data suggest that p53-dependent mechanisms regulating injuryresponsive fibroblast plasticity in the heart also regulate plasticity of glial cells and highlight the potential role for astrocyte cellular plasticity to modulate scar formation in the CNS after injury. Artificial reprogramming of resident adult astrocytes in vivo has been previously reported with GFAP-promoterdriven overexpression of Sox2 in the brain and spinal cord driving differentiated astrocytes into a functional neuronal phenotype [31, 32] . Other reprogramming strategies have also demonstrated the ability of both transplanted human and intrinsic mouse astrocytes to differentiate into neuronal cell populations [31, 33, 34] . While the artificial transdifferentiation of astrocytes into neurons is intriguing and holds potential therapeutic promise, the intrinsic cellular plasticity of astrocytes to repair the brain by augmenting angiogenesis and potentially reducing glial scar formation is a novel and attractive translational target. The fact that astrocytes harbor this particular intrinsic transdifferentiation potential towards an endothelial phenotype is not necessarily surprising. Astrocytes have a wide variety of functions in both the resting and injured nervous system [35] and share a close functional relationship with endothelial cells both during development and into adulthood [29, [36] [37] [38] . This study supports this close relationship and identifies a previously unreported form of astrocyte transdifferentiation. After stroke, reactive gliosis and angiogenesis share a tightly regulated spatio-temporal relationship suggesting that the microenvironment adjacent to a stroke m a y p r o v i d e a f e r t i l e m i l i e u t o p r o m o t e t h i s transdifferentiation phenomenon. This study demonstrates that an injury stimulus already activates the cellular machinery to provoke astrocyte transdifferentiation, and translational promise might be realized with partial augmentation of this intrinsic process. Moreover, shared molecular mechanisms in scar-forming cells appear to be conserved in both the heart and brain, providing a single strategy with implications for repair in multiple organs.
In adult differentiated cells, the tumor-suppressor gene, p53, acts as a cellular injury response element known to react to a wide variety of cellular insults resulting in apoptosis, cell cycle arrest, and senescence [39, 40] . The response to p53 is highly dependent on the cell type, the cellular environment, and the type of injury [41] . In astrocytes, p53 has been shown to promote cell cycle arrest [42] [43] [44] [45] , act as a nitric oxide (NO)-dependent signal to mitochondria to promote cell death [46] , promote astroglial hypertrophy after NMDA-mediated excitotoxicity [47] , and induce astroglial proliferation and hypertrophy in the retina with modest overexpression [48] . Microarray analysis of hypoxic primary human astrocytes revealed selective alteration of p53 [49] . Thus, although well described to play a multi-faceted role in regulating the outcome of cell stress in a variety of cell types and tissues, this report highlights the importance of p53 in regulating astroglial cell fate following stress. The precise role of p53 in astrocytes and the astroglial response to injury remains unknown [50] . In this study, hypoxia had no additive effect on endothelial gene expression compared to serum deprivation alone, suggesting that the key driver for astrocyte cellular plasticity is through a withdrawal of growth factors or cell surface energy detection that ultimately signal through p53. While we have shown that p53 is required for this astrocytic cellular plasticity, p53 agonism did not produce additive effects on either endothelial gene expression or functional angiogenic activity. This indicates that additional molecular pathways beyond p53 are needed to stimulate this cellular transition in astrocytes.
Gene expression analysis demonstrated that the expression profile of serum-deprived astrocytes shares more similarity with a known endothelial cell profile than with a known astrocyte profile, though many of the cell-type-specific genes do not vary. This is likely secondary to the stochastic nature of gene expression and cellular transition (i.e., all astrocytes subjected to serum deprivation do not transition into an endothelial phenotype or to the same degree). Indeed, comparative bioinformatics with serum-deprived cardiac fibroblasts that respond to myocardial ischemia with a similar p53-dependent cellular plasticity and become functional endothelial cells in vivo [12] illustrates that there is substantial overlap in the differentially expressed genes including 49 shared transcription factors (Fig. 5d) . One transcriptional system that provides a link between cell surface signaling, p53, and a regenerative program is the p300/CBP system (Supplemental Figure 6 ). This system is directly implicated by pathway analysis of both the up-and downregulated shared transcription factor list between serumdeprived astrocytes and cardiac fibroblasts (Supplemental Table 3 ). In the brain, the p300/CBP system has been shown to promote axonal regeneration [51] , neurogenesis, and memory extension [52] , suggesting that it has an active role in regenerative pathways in the CNS. Moreover, this system has been linked to determination of neural or glial fate in neural progenitors by its differential temporal association with neurogenin or STAT and the control of Smads and cell surface BMP signaling [53] . This interesting transcriptional control system that helps to regulate glial cell fate in the CNS may also play a role in regulating intrinsic injury-induced astrocyte transdifferentiation.
In summary, this study identifies, for the first time, an ability of astrocytes to adopt endothelial cell fates in a p53-dependent manner. Although currently unclear if astrocytes are capable of this injury-provoked cellular transition in vivo, the modulation of similar molecular mechanisms to regulate fibroblast endothelial transitions and post-injury scarring in vivo in the heart illustrates the potential ability of this mechanism to regulate glial scarring. Future studies with fate mapping of astrocytes will demonstrate the physiological and therapeutic significance of astrocyte-endothelial cellular transitions in vivo. Any approach that reduces CNS scar formation and promotes recovery after injury holds therapeutic promise for neural repair.
